Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled PA101B for uremic pruritus in hemodialysis patients
2015-004794-33Phase 2Completed
- Sponsor
- Patara Pharma
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sodium cromoglycate in chronic kidney disease-associated pruritus (CKD-aP) (2 arms), sponsored by Patara Pharma. Primary endpoint: Change from baseline in severity of pruritus at Week 7. Started Jan 2016; status: completed.
02
Drugs
sodium cromoglycate
03
Conditions
chronic kidney disease-associated pruritus (CKD-aP)
Beyond the preview
Go deeper on 2015-004794-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004794-33.